Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $393.84 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $170.76 | 3 | $0 (2018) |
| PFIZER INC. | $91.35 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $60.99 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $49.56 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $21.18 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $94.74 | 4 | Novartis Pharmaceuticals Corporation ($49.56) |
| 2023 | $78.31 | 4 | PFIZER INC. ($38.39) |
| 2022 | $36.21 | 2 | Janssen Pharmaceuticals, Inc ($18.97) |
| 2018 | $30.78 | 2 | Allergan Inc. ($16.96) |
| 2017 | $153.80 | 2 | Allergan Inc. ($153.80) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/09/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/26/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/26/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/27/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/19/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/15/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $76.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/13/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $76.90 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 531 | 812 | $259,100 | $67,340 |
| 2022 | 7 | 461 | 698 | $209,439 | $53,840 |
| 2021 | 7 | 538 | 944 | $262,047 | $66,945 |
| 2020 | 7 | 509 | 844 | $259,077 | $64,869 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 177 | 395 | $94,608 | $24,748 | 26.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 183 | 206 | $71,140 | $18,605 | 26.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 90 | 91 | $47,775 | $11,988 | 25.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 58 | 89 | $32,075 | $8,464 | 26.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 12 | 16 | $8,752 | $2,340 | 26.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 15 | $4,750 | $1,194 | 25.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 126 | 296 | $63,614 | $16,610 | 26.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 139 | 154 | $48,492 | $12,418 | 25.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 63 | $37,680 | $9,762 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 66 | 112 | $34,590 | $9,185 | 26.6% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 28 | 29 | $15,628 | $3,737 | 23.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 31 | 31 | $6,653 | $1,456 | 21.9% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 11 | 13 | $2,782 | $671.70 | 24.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 199 | 582 | $126,364 | $33,031 | 26.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 146 | 151 | $48,169 | $12,598 | 26.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 77 | 78 | $47,148 | $10,988 | 23.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 29 | 29 | $15,913 | $4,060 | 25.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 55 | 57 | $12,374 | $3,088 | 25.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 20 | $6,220 | $1,621 | 26.1% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 20 | 27 | $5,859 | $1,559 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 185 | 507 | $112,538 | $28,868 | 25.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 138 | 145 | $47,316 | $12,106 | 25.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 72 | 73 | $45,399 | $10,943 | 24.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 42 | 42 | $23,898 | $6,077 | 25.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 18 | 18 | $15,358 | $3,121 | 20.3% |
About Dr. Robinson Trevil, D.O
Dr. Robinson Trevil, D.O is a Internal Medicine healthcare provider based in Danville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1922366608.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robinson Trevil, D.O has received a total of $393.84 in payments from pharmaceutical and medical device companies, with $94.74 received in 2024. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($393.84).
As a Medicare-enrolled provider, Trevil has provided services to 2,039 Medicare beneficiaries, totaling 3,298 services with total Medicare billing of $252,993. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Danville, VA
- Active Since 05/01/2012
- Last Updated 09/10/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1922366608
Products in Payments
- DALVANCE (Drug) $170.76
- ELIQUIS (Drug) $77.53
- XARELTO (Drug) $60.99
- LEQVIO (Drug) $25.66
- ENTRESTO (Drug) $23.90
- LOKELMA (Drug) $21.18
- CHANTIX (Drug) $13.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Danville
Dr. Christopher Still, D.o, D.O
Internal Medicine — Payments: $461,951
Dr. Brendan Carry, M.d, M.D
Internal Medicine — Payments: $209,824
Prince Anand, M.d, M.D
Internal Medicine — Payments: $188,555
Jessica Mckee, D.o, D.O
Internal Medicine — Payments: $57,390
Michael Caplan, Md, MD
Internal Medicine — Payments: $41,374
Dr. Mark Reginato, M.d, M.D
Internal Medicine — Payments: $23,997